GeneDx Holdings Corp.

Casdin & Castle Acquisition Corp. (Nasdaq: CMLF) is a blank-check company that completed its initial public offering in 2021 with a stated focus on the life sciences and healthcare technology sectors. Sponsored jointly by Casdin Capital and Castle Creek, two institutional investors with established track records in genomics and diagnostics, the vehicle was formed to pursue a single business combination with a high-growth target in the healthcare innovation space. The 10-Q filed July 21, 2021 reflects the SPAC's financials during its active search period, before its eventual announced combination with GeneDx, a genetic testing business. Sign up at SpacDesk for complete filing histories, sponsor profiles, and deal timelines on CMLF and the broader SPAC market.